Distinct actin cytoskeleton behaviour in primary and immortalised T-cells.


Journal

Journal of cell science
ISSN: 1477-9137
Titre abrégé: J Cell Sci
Pays: England
ID NLM: 0052457

Informations de publication

Date de publication:
04 09 2019
Historique:
received: 25 03 2019
accepted: 19 07 2019
pubmed: 16 8 2019
medline: 22 9 2020
entrez: 16 8 2019
Statut: epublish

Résumé

Cytoskeletal actin dynamics are crucial for the activation of T-cells. Immortalised Jurkat T-cells have been the model system of choice to examine and correlate the dynamics of the actin cytoskeleton and the immunological synapse leading to T-cell activation. However, it has remained unclear whether immortalised cellular systems, such as Jurkat T-cells can recapitulate the cytoskeletal behaviour of primary T-cells. Studies delineating the cytoskeletal behaviour of Jurkat T-cells in comparison to primary T-cells are lacking. Here, we employ live-cell super-resolution microscopy to investigate the cytoskeletal actin organisation and dynamics of living primary and immortalised Jurkat T-cells at the appropriate spatiotemporal resolution. Under comparable activation conditions, we found differences in the architectural organisation and dynamics of Jurkat and primary mouse and human T-cells. Although the three main actin network architectures in Jurkat T-cells were reminiscent of primary T-cells, there were differences in the organisation and molecular mechanisms underlying these networks. Our results highlight mechanistic distinctions in the T-cell model system most utilised to study cytoskeletal actin dynamics.

Identifiants

pubmed: 31413071
pii: jcs.232322
doi: 10.1242/jcs.232322
pmc: PMC6898998
pii:
doi:

Substances chimiques

Actins 0
Receptors, Antigen, T-Cell 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Wellcome Trust
ID : 212343/Z/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom

Informations de copyright

© 2019. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing or financial interests.

Références

Cell Rep. 2018 Jan 23;22(4):979-991
pubmed: 29386139
Sci Adv. 2017 Jun 21;3(6):e1603032
pubmed: 28691087
N Engl J Med. 2000 Oct 5;343(14):1020-34
pubmed: 11018170
Sci Rep. 2017 Jul 14;7(1):5416
pubmed: 28710416
J Cell Biol. 2015 Feb 16;208(4):475-91
pubmed: 25666810
Nat Immunol. 2012 Jul 01;13(8):787-95
pubmed: 22751140
Elife. 2015 Mar 11;4:null
pubmed: 25758716
J Cell Sci. 2007 Mar 1;120(Pt 5):723-30
pubmed: 17314246
Nat Rev Immunol. 2004 Apr;4(4):301-8
pubmed: 15057788
Immunity. 2015 May 19;42(5):864-76
pubmed: 25992860
J Cell Biol. 2016 Nov 7;215(3):383-399
pubmed: 27799367
Curr Opin Cell Biol. 2008 Oct;20(5):533-40
pubmed: 18595683
Front Cell Dev Biol. 2018 Sep 19;6:116
pubmed: 30283780
Commun Biol. 2019 Mar 7;2:93
pubmed: 30854485
Sci Rep. 2015 Nov 13;5:16487
pubmed: 26563585
Curr Biol. 2018 Feb 19;28(4):489-502.e9
pubmed: 29398219
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20296-301
pubmed: 18077330
Trends Cell Biol. 2002 Mar;12(3):112-20
pubmed: 11859023
PLoS Biol. 2011 Sep;9(9):e1001151
pubmed: 21931536
Cell Rep. 2019 Mar 19;26(12):3369-3379.e5
pubmed: 30893608
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):5908-5913
pubmed: 30850545
Cell. 2004 Aug 6;118(3):363-73
pubmed: 15294161

Auteurs

Huw Colin-York (H)

MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford OX3 9DS, UK.

Sudha Kumari (S)

Koch Institute of Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge 02139, USA kumars04@mit.edu marco.fritzsche@rdm.ox.ac.uk.

Liliana Barbieri (L)

MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford OX3 9DS, UK.

Lena Cords (L)

MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford OX3 9DS, UK.

Marco Fritzsche (M)

MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Headley Way, Oxford OX3 9DS, UK kumars04@mit.edu marco.fritzsche@rdm.ox.ac.uk.
Kennedy Institute for Rheumatology, University of Oxford, Roosevelt Drive, Oxford OX3 7LF, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH